News On Revance Therapeutics Inc. (RVNC) Now Under CRWN.XX

Dow JonesFeb 6 17:08 ET

Revance Therapeutics Acquired by Crown Laboratories

MT NewswiresFeb 6 10:52 ET

Express News | Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer

ReutersFeb 5 08:00 ET

Press Release: Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer

Dow JonesFeb 5 08:00 ET

Press Release: Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline

Dow JonesJan 31 07:30 ET

Mizuho Securities Maintains Revance Therapeutics(RVNC.US) With Hold Rating

Moomoo NewsJan 31 03:33 ET · Ratings